tiprankstipranks

Mark Coleman Insider Profile

18 Followers
Mark Coleman, Director at Axsome Therapeutics, holds 428.95K shares in Axsome Therapeutics (Ticker: AXSM).
tipranks
Mark Coleman

Mark Coleman
Axsome Therapeutics (AXSM)
Director

Ranked #391 out of 98,624 Corporate Insiders

Profitable Transactions

75%
6 out of 8 Profitable Transactions

Average Return

+113.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$31M
100.00%
A breakdown of Mark Coleman's holdings

Insider Roles

Axsome Therapeutics
(AXSM)
Director
Roles that Mark Coleman holds in companies

Most Profitable Insider Trade

Stock:
Axsome Therapeutics
(AXSM)
Rating:Informative Buy
Date:Mar 21, 2019 - Mar 21, 2020
Return:+310.80%
The most profitable trade made by Mark Coleman

Mark Coleman's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Axsome Therapeutics
Sep 15, 2023
Director
Uninformative Sell
2.22M
$30.76M
Success Rate for
AXSM
6 out of 8 profitable transactions on
AXSM
75%
Average Return for
AXSM
Average return per transaction on
AXSM
+113.16%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
May 15, 2019
Informative Buy
$99.70K
-
$21.44
+277.70%
Jun 27, 2019
Informative Buy
$374.28K
-
$23.10
+237.80%
Jun 30, 2020
Informative Buy
$51.02K
-
$78.50
-18.00%
Aug 20, 2020
Uninformative Buy
$0.00
-
$0.00
Nov 22, 2021
Informative Buy
$50.18K
-
$35.09
+55.30%
List of latest transactions for each holding click on a transaction to see Mark Coleman's performance on stock

Mark Coleman insider profile FAQ

What is the percentage of profitable transactions made by Mark Coleman?
The percentage of profitable transactions made by Mark Coleman is 75%.
    What is the average return per transaction made by Mark Coleman?
    The average return per transaction made by Mark Coleman is 113.10%.
      What stocks does Mark Coleman hold?
      Mark Coleman holds: AXSM stocks.
        What was Mark Coleman’s latest transaction?
        Mark Coleman latest transaction was an Uninformative Sell of $2.22M.
          What was Mark Coleman's most profitable transaction?
          Mark Coleman’s most profitable transaction was an Informative Buy of AXSM stock on March 21, 2019. The return on the trade was 310.80%.
            What is Mark Coleman's role in Axsome Therapeutics?
            Mark Coleman's role in Axsome Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.